OWC Pharmaceutical Research Corp. announced the resignation of Mr. Jeffrey Friedland as a member of the company's advisory board, effective immediately. The company has been made aware of the fact that the United States Securities and Exchange Commission has commenced a civil injunctive action against Mr. Friedland and two related entities by the filing of a complaint in the United States District Court for the District of Colorado. The SEC alleges in the complaint that the Friedland Defendants engaged in a nearly $7 million securities fraud scheme to conceal the nature of interest in OWC Pharmaceutical Research Corp. to allow him to unload his considerable holdings in OWC stock into the marked that he helped to artificially inflate.